Pliant Therapeutics, Inc. · NASDAQ:PLRX

Citadel Advisors LLC reported a 5.00% stake in Pliant Therapeutics, Inc. (Schedule 13G)

Event Feb 2, 2026 · Filed Feb 9, 2026

Citadel Advisors LLC reported a 5.00% stake in Pliant Therapeutics, Inc., 3,042,133 shares, as a passive investor on Feb 2, 2026. Filed Feb 9, 2026 (Schedule 13G).

Stake
5.00%
Shares
3,042,133
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC3.40%2,099,798
Citadel Advisors Holdings LP3.40%2,099,798
Citadel GP LLC3.40%2,099,798
Citadel Securities LLC1.50%913,609
Citadel Securities Group LP1.50%942,335
Citadel Securities GP LLC1.50%942,335
Kenneth Griffin5.00%3,042,133

Source

View original at SEC

Related